History
Documents created during the development process.
Review proposal consultation
Final appraisal determination
Draft guidance
Assessment report sent for information
Protocol
-
Protocol
-
Response to comments on scope and matrix
-
Response to comments on scope and matrix
-
Equality impact assessment form
-
Equality impact assessment form
-
Final matrix
-
Final matrix
-
Final scope
-
Final scope
-
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): draft scope (post-referral)
-
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): draft scope (post-referral)
-
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): provisional matrix (post-referral)
-
Diabetes (type 2) - canagliflozin, dapagliflozin and empagliflozin (monotherapy): provisional matrix (post-referral)
-